MedPath

GE Healthcare B.V.

GE Healthcare B.V. logo
🇳🇱Netherlands
Ownership
Private, Subsidiary
Established
2002-01-01
Employees
-
Market Cap
-
Website
http://www.gehealthcare.nl

Clinical Trials

31

Active:0
Completed:29

Trial Phases

4 Phases

Phase 1:3
Phase 2:2
Phase 3:7
+1 more phases

Drug Approvals

1

EMA:1

Drug Approvals

DaTSCAN

Authorization Status
Authorised
Approval Date
Jul 27, 2000
EMA

Clinical Trials

Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials

Phase 3
7 (41.2%)
Phase 4
5 (29.4%)
Phase 1
3 (17.6%)
Phase 2
2 (11.8%)

Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers

Phase 1
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
First Posted Date
2011-07-01
Last Posted Date
2012-05-07
Lead Sponsor
Nycomed
Target Recruit Count
36
Registration Number
NCT01386541
Locations
🇩🇪

Nycomed Investigational site, Mannheim, Germany

Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-12-09
Last Posted Date
2012-05-07
Lead Sponsor
Nycomed
Target Recruit Count
72
Registration Number
NCT01028924
Locations
🇩🇪

Nycomed GmbH, Konstanz, Germany

Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Phase 1
Completed
Conditions
Renal Impairment
Interventions
First Posted Date
2009-12-09
Last Posted Date
2012-05-07
Lead Sponsor
Nycomed
Target Recruit Count
36
Registration Number
NCT01028768
Locations
🇩🇪

Nycomed GmbH, Konstanz, Germany

Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders

Completed
Conditions
Gastroesophageal Reflux Disease
Sleep Disorders
Non-Erosive Reflux Disease
Interventions
First Posted Date
2009-01-27
Last Posted Date
2012-05-08
Lead Sponsor
Nycomed
Target Recruit Count
1045
Registration Number
NCT00830115
Locations
🇩🇪

Nycomed Deutschland GmbH, Zwickau, Germany

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease

Completed
Conditions
Gastroesophageal Reflux Disease
Interventions
First Posted Date
2009-01-27
Last Posted Date
2012-05-08
Lead Sponsor
Nycomed
Target Recruit Count
4188
Registration Number
NCT00829738
Locations
🇩🇪

Nycomed Deutschland GmbH, Überlingen, Germany

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath